Paul Tudor Jones's OPK Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 244,821 shares of OPKO Health, Inc. (OPK) worth $279,096, representing 0.00% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in OPK, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2022, adding 308,800 shares. Largest reduction occurred in Q3 2021, reducing 213,330 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's OPKO Health (OPK) Holding Value Over Time
Track share changes against reported price movement
Quarterly OPKO Health (OPK) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2023 | -95,070 | Reduce 27.97% | 244,821 | $1.60 |
| Q1 2023 | -1,214 | Reduce 0.36% | 339,891 | $0.00 |
| Q3 2022 | +308,800 | Add 955.89% | 341,105 | $1.89 |
| Q2 2022 | +15,410 | Add 91.21% | 32,305 | $2.54 |
| Q1 2022 | +16,895 | New Buy | 16,895 | $3.43 |
| Q3 2021 | -213,330 | Sold Out | 0 | $0.00 |
| Q2 2021 | +176,957 | Add 486.51% | 213,330 | $4.05 |
| Q1 2021 | -126,952 | Reduce 77.73% | 36,373 | $4.29 |
| Q4 2020 | +82,713 | Add 102.61% | 163,325 | $3.95 |
| Q3 2020 | +80,612 | New Buy | 80,612 | $3.68 |
| Q4 2019 | -16,944 | Sold Out | 0 | $0.00 |
| Q3 2019 | +16,944 | New Buy | 16,944 | $2.07 |
| Q2 2019 | -85,189 | Sold Out | 0 | $0.00 |
| Q1 2019 | -48,328 | Reduce 36.20% | 85,189 | $2.61 |
| Q4 2018 | -848 | Reduce 0.63% | 133,517 | $3.01 |
| Q3 2018 | +134,365 | New Buy | 134,365 | $3.46 |
| Q2 2017 | -93,342 | Sold Out | 0 | $0.00 |
| Q1 2017 | +93,342 | New Buy | 93,342 | $8.00 |
| Q4 2016 | -36,248 | Sold Out | 0 | $0.00 |
| Q3 2016 | +9,075 | Add 33.40% | 36,248 | $10.59 |
| Q2 2016 | +27,173 | New Buy | 27,173 | $9.35 |
| Q1 2016 | -26,500 | Sold Out | 0 | $0.00 |
| Q4 2015 | -20,300 | Reduce 43.38% | 26,500 | $10.04 |
| Q3 2015 | -72,991 | Reduce 60.93% | 46,800 | $8.42 |
| Q2 2015 | +81,654 | Add 214.11% | 119,791 | $16.08 |
| Q1 2015 | +38,137 | New Buy | 38,137 | $14.16 |
| Q3 2014 | -13,145 | Sold Out | 0 | $0.00 |
| Q2 2014 | +892 | Add 7.28% | 13,145 | $8.82 |
| Q1 2014 | +12,253 | New Buy | 12,253 | $9.30 |
Paul Tudor Jones's OPKO Health Investment FAQs
Paul Tudor Jones first purchased OPKO Health, Inc. (OPK) in Q1 2014, acquiring 12,253 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held OPKO Health, Inc. (OPK) for 41 quarters since Q1 2014.
Paul Tudor Jones's largest addition to OPKO Health, Inc. (OPK) was in Q3 2022, adding 341,105 shares worth $645,000.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 244,821 shares of OPKO Health, Inc. (OPK), valued at approximately $279,096.
As of the Q1 2026 filing, OPKO Health, Inc. (OPK) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in OPKO Health, Inc. (OPK) was 341,105 shares, as reported at the end of Q3 2022.